[EN] SMALL MOLECULE INHIBITORS OF SRC TYROSINE KINASE<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE TYROSINE KINASE SRC
申请人:DANA FARBER CANCER INST INC
公开号:WO2020257385A1
公开(公告)日:2020-12-24
Disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof. Also disclosed herein are methods of using the compounds of Formula (I) in the treatment of certain diseases (e.g., cancer).
Copper-Catalyzed Direct Nitration on Aryl C–H Bonds by Concomitant Azidation–Oxidation with TMS Azide and TBHP under Aerobic Conditions
作者:Botla Vinayak、Malapaka Chandrasekharam
DOI:10.1021/acs.orglett.7b01489
日期:2017.7.7
An unprecedented copper-catalyzed in situ azidation–oxidation for the nitration of anilides and sulfonamides has been developed by direct CAr–H functionalization. This novel and efficient nitration protocol is achieved employing TMSN3 and TBHP without the exclusion of air or moisture. The synthetic applications of the 2-nitroanilides have been explored.
通过直接的C Ar -H功能化,开发出了前所未有的铜催化原位叠氮化氧化技术,用于苯胺和磺酰胺的硝化。使用TMSN 3和TBHP可以实现这种新颖而高效的硝化方案,而不会排除空气或湿气。已经研究了2-硝基苯胺的合成应用。
In silico, synthesis and anticancer evaluation of benzamide tryptamine derivatives as novel eEF2K inhibitors
effectively kill cancer cells without affecting the function of normal cells. Therefore, eEF2K is a promising new target for cancer therapy. In this study, a series of benzamide tryptamine derivatives were designed and synthesized as novel eEF2K inhibitors. The druggability properties of the synthesized compounds were predicted in silico and performed well. The MTT assay indicated that most of these compounds